Study Start-Up

Study Start-Up

From the very beginning, you have opportunities to set up your study for success. Let us help you accelerate and optimize your study’s start-up.

Position your study start-up for success

A successful study start-up relies on a host of critical factors. According to Tufts Center for Drug Development, 80 percent of delayed trials are often related to patient recruitment, and 48% of sites miss their targets. These realities are forcing biopharmaceutical firms to re-examine how they execute study start-up.

IQVIA可以帮助您快速开始学习。

  • Data driven。我们的整体数据驱动解决方案集成了技术,见解和经过验证的过程,以减少时间表并将您的临床试验定位为成功。王者荣耀kpl外围投注
  • Unify your processes。IQVIA将协议验证,可行性和计划,现场选择和合同,监管/道德信息,文档管理和患者招聘作为完全集成的过程,促进入学率 - 87%的参与试验已实现了定时入学率
  • 优化和加速。Our framework of tools, processes and expertise can get your clinical trial up and running quickly – up to 30% faster than industry benchmark in certain therapeutic areas.

From the very beginning, you have opportunities to set up your study for success. Start-up delays and late completions don’t have to be part of your clinical development story.

让我们帮助您加速并优化研究的初创企业。

相关解决方案

Contact Us